Overall, we have evidence that GLP-1 meds offer benefits beyond just the weight-loss effect
Keep out of reach of individuals not involved in the designated research project
When treatment is titrated toward weight loss rather than glycemic control, average reductions can be much larger, with a trial-level result of 14.9% body weight loss over 68 weeks under a weight-focused escalation protocol
Though chemically speaking, it is alcohol (as in, it has an -OH group in its molecule), its properties are totally different from the properties of low molecular weight or drying alcohols such as denat
Unlike Wegovy, which is brand-name only, PlexusDx compounded semaglutide injections are HSA and FSA eligible, allowing veterans to use tax-advantaged health savings accounts to pay for treatment
[PubMed] Habegger KM, Heppner KM, Geary N, et al